161 related articles for article (PubMed ID: 20947312)
1. The Nationwide Austrian Aspergillus Registry: a prospective data collection on epidemiology, therapy and outcome of invasive mould infections in immunocompromised and/or immunosuppressed patients.
Perkhofer S; Lass-Flörl C; Hell M; Russ G; Krause R; Hönigl M; Geltner C; Auberger J; Gastl G; Mitterbauer M; Willinger B; Knöbl P; Resch G; Waldner R; Makrai A; Hartmann G; Girschikofsky M; Greil R
Int J Antimicrob Agents; 2010 Dec; 36(6):531-6. PubMed ID: 20947312
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.
Neofytos D; Horn D; Anaissie E; Steinbach W; Olyaei A; Fishman J; Pfaller M; Chang C; Webster K; Marr K
Clin Infect Dis; 2009 Feb; 48(3):265-73. PubMed ID: 19115967
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients.
Neofytos D; Fishman JA; Horn D; Anaissie E; Chang CH; Olyaei A; Pfaller M; Steinbach WJ; Webster KM; Marr KA
Transpl Infect Dis; 2010 Jun; 12(3):220-9. PubMed ID: 20113459
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology and outcomes of patients with invasive mould infections: a retrospective observational study from a single centre (2005-2009).
Klingspor L; Saaedi B; Ljungman P; Szakos A
Mycoses; 2015 Aug; 58(8):470-7. PubMed ID: 26152371
[TBL] [Abstract][Full Text] [Related]
5. Invasive aspergillosis in a tertiary-care hospital in Thailand.
Kiertiburanakul S; Thibbadee C; Santanirand P
J Med Assoc Thai; 2007 May; 90(5):895-902. PubMed ID: 17596043
[TBL] [Abstract][Full Text] [Related]
6. [Aspergillosis in pulmonary transplantation].
de Pablo A; Ussetti P; Cruz Carreño M; Lázaro T; Ferreiro MJ; López A; Mendaza P; Estada J
Enferm Infecc Microbiol Clin; 2000 May; 18(5):209-14. PubMed ID: 10974763
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
Horn DL; Neofytos D; Anaissie EJ; Fishman JA; Steinbach WJ; Olyaei AJ; Marr KA; Pfaller MA; Chang CH; Webster KM
Clin Infect Dis; 2009 Jun; 48(12):1695-703. PubMed ID: 19441981
[TBL] [Abstract][Full Text] [Related]
8. Presentation of the PATH Alliance registry for prospective data collection and analysis of the epidemiology, therapy, and outcomes of invasive fungal infections.
Horn DL; Fishman JA; Steinbach WJ; Anaissie EJ; Marr KA; Olyaei AJ; Pfaller MA; Weiss MA; Webster KM; Neofytos D
Diagn Microbiol Infect Dis; 2007 Dec; 59(4):407-14. PubMed ID: 17888614
[TBL] [Abstract][Full Text] [Related]
9. Invasive mold infections in iatrogenically immunocompromised children: an eight-yr review.
Al-Rezqi A; Hawkes M; Doyle J; Richardson SE; Allen U
Pediatr Transplant; 2009 Aug; 13(5):545-52. PubMed ID: 18992060
[TBL] [Abstract][Full Text] [Related]
10. Liposomal amphotericin B (AmBisome) efficacy in confirmed invasive aspergillosis and other filamentous fungal infections in immunocompromised hosts: a pooled analysis.
Cordonnier C; Bresnik M; Ebrahimi R
Mycoses; 2007 May; 50(3):205-9. PubMed ID: 17472618
[TBL] [Abstract][Full Text] [Related]
11. Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry.
Steinbach WJ; Marr KA; Anaissie EJ; Azie N; Quan SP; Meier-Kriesche HU; Apewokin S; Horn DL
J Infect; 2012 Nov; 65(5):453-64. PubMed ID: 22898389
[TBL] [Abstract][Full Text] [Related]
12. Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi.
Husain S; Alexander BD; Munoz P; Avery RK; Houston S; Pruett T; Jacobs R; Dominguez EA; Tollemar JG; Baumgarten K; Yu CM; Wagener MM; Linden P; Kusne S; Singh N
Clin Infect Dis; 2003 Jul; 37(2):221-9. PubMed ID: 12856215
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).
Leroy O; Gangneux JP; Montravers P; Mira JP; Gouin F; Sollet JP; Carlet J; Reynes J; Rosenheim M; Regnier B; Lortholary O;
Crit Care Med; 2009 May; 37(5):1612-8. PubMed ID: 19325476
[TBL] [Abstract][Full Text] [Related]
14. Outcome and medical costs of patients with invasive aspergillosis and acute myelogenous leukemia-myelodysplastic syndrome treated with intensive chemotherapy: an observational study.
Slobbe L; Polinder S; Doorduijn JK; Lugtenburg PJ; el Barzouhi A; Steyerberg EW; Rijnders BJ
Clin Infect Dis; 2008 Dec; 47(12):1507-12. PubMed ID: 18990068
[TBL] [Abstract][Full Text] [Related]
15. [Guideline based treatment of invasive aspergillosis].
Karthaus M
Mycoses; 2010 May; 53 Suppl 1():36-43. PubMed ID: 20433655
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of invasive fungal infection.
Castón-Osorio JJ; Rivero A; Torre-Cisneros J
Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S103-9. PubMed ID: 19013332
[TBL] [Abstract][Full Text] [Related]
17. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database.
Kontoyiannis DP; Marr KA; Park BJ; Alexander BD; Anaissie EJ; Walsh TJ; Ito J; Andes DR; Baddley JW; Brown JM; Brumble LM; Freifeld AG; Hadley S; Herwaldt LA; Kauffman CA; Knapp K; Lyon GM; Morrison VA; Papanicolaou G; Patterson TF; Perl TM; Schuster MG; Walker R; Wannemuehler KA; Wingard JR; Chiller TM; Pappas PG
Clin Infect Dis; 2010 Apr; 50(8):1091-100. PubMed ID: 20218877
[TBL] [Abstract][Full Text] [Related]
18. [Risk factors for invasive fungal infections during intensive chemotherapy of acute leukemia--retrospective study].
Zupanić-Krmek D; Nemet D; Mrsić M; Bogdanić V; Labar B; Jandrlić M; Kalenić S
Acta Med Croatica; 2004; 58(4):275-84. PubMed ID: 15700683
[TBL] [Abstract][Full Text] [Related]
19. Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases.
Kontoyiannis DP; Lionakis MS; Lewis RE; Chamilos G; Healy M; Perego C; Safdar A; Kantarjian H; Champlin R; Walsh TJ; Raad II
J Infect Dis; 2005 Apr; 191(8):1350-60. PubMed ID: 15776383
[TBL] [Abstract][Full Text] [Related]
20. [Surveillance of invasive mold infections in lung transplant recipients: effect of antimycotic prophylaxis with itraconazole and voriconazole].
Mattner F; Chaberny IF; Weissbrodt H; Fischer S; Gastmeier P; Haubitz B; Gottlieb J; Mattner L; Strueber M
Mycoses; 2005; 48 Suppl 1():51-5. PubMed ID: 15826288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
